Superworth

OneMedNet EPS ONMD

Diluted earnings per share by quarter and over the last twelve months, from 2021.

Last 12 months, to Jun 30, 2026
−$1.50
Latest quarter, Q2 FY26
−$0.40
−157% on a year earlier
Fiscal year 2025
−$0.60

OneMedNet's earnings per share was −$1.50 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.40, down 157% on the same quarter a year before.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.60n/a
FY2024−$3.60n/a
FY2023−$77.00n/a
FY2022−$5.40n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.40−157%−$1.50
Q1 FY26−$0.40n/a−$0.40
Q4 FY25−$0.60n/a−$0.60
Q3 FY25−$0.10n/a−$0.70
Q2 FY25$0.70n/a−$1.30
Q1 FY25−$0.60n/a−$3.40
Q4 FY24−$0.70n/a−$3.60
Q3 FY24−$0.70n/a−$4.40
Q2 FY24−$1.40n/a−$36.00
Q1 FY24−$0.80n/a−$58.40
Q4 FY23−$1.50n/a−$77.00
Q3 FY23−$32.30−32400%−$83.10

Against its peers

Companies in Healthcare nearest OneMedNet's size, closest first, today.

CompanyEPS, 12 monthsGrowth
ONMDOneMedNet−$1.50
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ICCCImmucell$0.08−58% a year
KEQUKewaunee Scientific$2.76−33% a year
PDEXPro DEX$4.11+52% a year
PLXProtalix BioTherapeutics$0.23+283% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on OneMedNet

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.